Results 41 to 50 of about 13,200 (163)
Association of exacerbation under montelukast treatment with rs2660845 genotype.
, 2021 Association of exacerbation under montelukast treatment with rs2660845 genotype.
Esteban G. Burchard (8724966) +17 more
core +1 more source
The effects of Montelukast on depression and anxiety behaviors in rats
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Montelukast is a leukotriene receptor antagonist used for the treatment of chronic asthma and to relieve symptoms of seasonal allergies.
Ersoz Gonca
doaj
JPGN Reports, EarlyView.Abstract Tezepelumab is a human monoclonal antibody that binds to human thymic stromal lymphopoietin (TSLP), an epithelial cytokine that plays a role in Type 2 signaling. We describe a 17‐year‐old with a history of eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis who demonstrated response to tezepelumab with both clinical and histologic ...
Destiny Newsome +3 more
wiley +1 more source
Sodium Ions Affect GPR17 Conformational States and Functionality
Proteins: Structure, Function, and Bioinformatics, EarlyView.ABSTRACT Sodium is an allosteric modulator of several class‐A GPCR regulating active versus inactive conformation state and may be a critical issue for the optimization of crystallization procedures. Herein, the role of Na+ in the regulation of GPR17 conformational states was studied through MD simulations of GPR17 wild‐type and mutated on two ...
Luca Palazzolo +6 more
wiley +1 more source
Montelukast in translated forms.
, 2016 Montelukast in translated forms.
Rachel Bryan (5666281) +4 more
core +1 more source
, 2021 In 2008, the Food and Drug Administration of the US issued a warning about the neuropsychiatric side effects of montelukast. Previous clinical studies on montelukast have reported conflicting results and, to the best of our knowledge, no experimental ...
Onder, Sevgen +4 more
core +1 more source
Phytotherapy Research, EarlyView.ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit +5 more
wiley +1 more source
Evaluation of the effect of montelukast on cadmium induced toxicity in human embryonic kidney cells (HEK-293) [PDF]
مجله علمی دانشگاه علوم پزشکی کردستان, 2019 Background and Aim: Industrialization of communities has resulted in a rise in cadmium accumulation in the plants, and also organs of human and animals. Kidney is the main target organ for cadmium accumulation and toxicity. The aim of this study was to
Kaviani F +4 more
doaj +2 more sources
Journal of Orthopaedic ReportsBackground: Arthrofibrosis causes debilitating stiffness and loss of range of motion following total knee arthroplasty (TKA). The primary treatment for early symptomatic stiffness is manipulation under anesthesia (MUA) within three months of index ...
Audrey Zhao +5 more
doaj +1 more source
Allergy, EarlyView.ABSTRACT Background To achieve adequate symptom control, patients with allergic rhinitis (AR) often need to increase their medication dose or add other treatments (co‐medication). We aimed to perform a systematic review to compare the efficacy and safety of AR medications for increased dose versus co‐medication.
Bernardo Sousa‐Pinto +44 more
wiley +1 more source